Amarantus Bioscience Holdings Inc (AMBS)

[the gipper]

AMBS progress re. MANF and diagnostic tests are doing nothing but solidify the determination of longs to hold, and add, and making more probable every day, a JV with a Big Pharma, or perhaps even an outright buyout attempt, which could easily lead to a bidding war. Rubinfeld and associates are not here because they have nothing better to do. They believe this is a diamond in the rough, and are applying their considerable experience and skill to help launch AMBS into IND status, and a national exchange. Future looking very bright indeed!